SaudiAjal is a leader in pharmaceutical research and development, food testing, and genetic diagnostics. It has the only bioequivalence /bioavailability centre in the GCC located in Riyadh. This centre is accredited and has already done more than 20 studies since the beginning of 2017. SaudiAjal has 40% Saudi employment ratio and is planning to get to 60% by the end of 2019. Currently, SaudiAjal is cooperating with Prince Sattam University to establish a world-class research and development pharma centre. Faculty members can carry out their research project in this centre, and students will get hands-on training on pharmaceutical formulation.